Surgery Partners reaffirms 2026 revenue $3.35B-$3.45B and adjusted EBITDA at least $530M as Idaho Falls sale nears close Surgery Partners (SGRY) Q2 2026 earnings call: $795M Idaho Falls divestiture, reaffirmed guidance, volume trends, payer mix and leverage. $$ seekingalpha.com seekingalpha.com / feeds seekingalpha-com-news / / #money / / 22 days 22d Share
